First Indian MRNA Vaccine Gets Nod For Phase 2/3 Trials
[email protected]08 Sep, 2021News
India's first mRNA vaccine HGCO19 received DCGI nod for Phase II/III clinical trials on Tuesday. The Covid-19 vaccine has been developed by Gennova Biopharmaceuticals Ltd, a Pune-based biotechnology company in partnership with the Department of Biotechnology.
Related Bookmarks
- India's First MRNA Covid Vaccine Safe In Early Trials, Say Regulators
- click to read more
- Adtech Leader Ezoic to Invest $12.4 Million Directly in Customers
- Digital Marketing Leader Sojern Partners with Roiback
- Drips Unveils Conversational AI Platform at Contact.io Conference
- Oxford brunch Bar | Tasty & healthy breakfast | Breakfast brunch bar
- https://www.stattimes.com/news/bbam-to-lease-two-airbus-a321p2f-to-lufthansa-cargo-air-cargo/
- Different Types of Tyre Treads and Their Uses
- Bitcoin Profit
- GEODIS in Hong Kong is accredited as an Authorized Economic Operator
Recent Profiles
89h
Attorney Adam Burke
Gaming Prism Private Limited
Litter Robot.ee
Casinos Online
Property Dekhlo
Unreguliert
Dignifyd Tech
R777
Rajesh Sam Suri